Canadian Cardiovascular Society
 
Canadian Cardiovascular Society

CUBED+ CCC 2020 Symposia

CUBED+ Upcoming Initiatives

CCC 2020 CUBED+ Symposia

Overall Learning Objectives:
At the conclusion of theses sessions, participants will be able to:

  • Describe the cardio-renal spectrum in type 2 diabetes (T2D);
  • Differentiate among the large outcome trials focused on the major comorbidities in T2D; and
  • Implement the recommendations of clinical practice guidelines and translate recent clinical trial evidence into risk-reduction approaches in T2D.

Access a catalogue of individual segments based on the two CUBED+ presentations from the 2020 CCC Congress by clicking on the boxes below.

PART 1

DIABETES AND HEART FAILURE: NEW EVIDENCE

Eileen O’Meara
MD, FRCPC
Cardiologist, Montreal Heart Institute
Professor of Medicine, Université de Montréal

Individual Learning Objectives:

  • Understand how diabetes and heart failure are closely interrelated;
  • Know which antihyperglycemic agents can modify heart failure outcomes in patients with and without diabetes; and
  • Learn about the proposed mechanisms of action of these agents to prevent heart failure related outcomes.

Browse the different segments on Diabetes and Heart Failure: New Evidence by clicking on any video below:

The Relationship Between diabetes and heart failure
Evolving Treatment of HF with Reduced Ejection Fraction

Conclusions & Clinical Pearls

DIABETES MELLITUS AND CARDIOVASCULAR DISEASE: NEW EVIDENCE AND NEW GUIDELINES

Subodh Verma
MD, PhD, FRCSC, FAHA
Professor of Surgery and Pharmacology and Toxicology, University of Toronto
Canadian Research Chair in Cardiovascular Surgery

Individual Learning Objectives:

  • Gain an appreciation of the new clinical practice guidelines on the use of antihyperglycemic agents in cardiovascular protection; and;
  • Learn about the recent clinical trial evidence in diabetes that have informed these changes in clinical guidelines.

Browse the different segments on Diabetes Mellitus and Cardiovascular Disease: New Evidence and New Guidelines by clicking on any video below

Cardiovascular Outcome Tirals (CVOTs) in Type 2 Diabetes: A Snapshot Review
European & American Guideline Updates Based on Recent CVOTs
Diabetes Canada 2020 Guideline Update Based on Recent CVOTs
Addressing Clinical Inertia in the Use of Antihypergylcemics with Demonstrated CV Benefits

PART 2

DIABETIC KIDNEY DISEASE: KEY MESSAGES FOR CARDIOLOGISTS

Louise Moist
MD, MSc, CCPE, FRCPC
Professor of Medicine Epidemiology and Biostatistics
Nephrologist, London Health Sciences Centre
Deputy Chair Division of Nephrology
South West LHIN Internal Medicine Lead
Schulich School of Medicine & Dentistry, Western University

Individual Learning Objectives:

  • To appreciate the impact of Diabetic Kidney Disease (DKD) on cardiovascular outcomes; and
  • To describe a shared platform for optimizing patient management.

Browse the different segments on Diabetic Kidney Disease: Key Messages for Cardiologists by clicking on any video below:

Impact of Diabetic Kidney Disease (DKD) on Cardiovascular (CV) Outcomes

Treatment of DKD: Current Evidence, Guideline Recommendations, and Importance of Team-Based Care

DIABETIC KIDNEY DISEASE: KEY MESSAGES FOR CARDIOLOGISTS

Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
Endocrinologist, St. Michael’s Hospital
Professor of Medicine and Nutritional Sciences, University of Toronto

Individual Learning Objectives:

  • To review evidence on the treatment of dyslipidemia in diabetes;
  • To highlight emerging new therapies for the treatment of dyslipidemia; and
  • To understand the implications of various lipid guidelines.

Browse the different segments on Diabetes Mellitus and Lipids: New Drugs, New Data by clicking on any video below:

Treatment of Dyslipidemia in Diabetes: Evidence Review
Current Clinical Practice Guidelines for Lipid Management
Treatment of Hypertriglyceridemia: Evidence Review
Emergency New Therapies for the Treatment of Dyslipidemia

CUBED Scientific Planning Committee

Subodh Verma
MD, PhD, FRCSC, FAHA
Professor of Surgery and Pharmacology and Toxicology, University of Toronto
Canadian Research Chair in Cardiovascular Surgery
Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
Endocrinologist, St. Michael’s Hospital
Professor of Medicine and Nutritional Sciences, University of Toronto
Eileen O’Meara
MD, FRCPC
Cardiologist, Montreal Heart Institute
Professor of Medicine, Université de Montréal
Back to top